Laurina (Desogestrel, Ethinylestradiol)

The desogestrel component suppresses the mid‑cycle surge of luteinising hormone and follicle‑stimulating hormone, stopping ovulation. Ethinylestradiol stabilises the uterine lining and, together with desogestrel, thickens cervical mucus, reducing the chance of fertilisation and implantation.

The dosing regimen for Laurina is determined by the prescribing healthcare professional. Typically, it is taken as one tablet daily at the same time each day, but the exact schedule and duration should follow the prescriber’s instructions.

Laurina is classified as Pregnancy Category X, meaning it must not be used during pregnancy because it can cause harm to the fetus. It is also not recommended while breastfeeding, as hormonal components may pass into breast milk and affect the infant.

To order Laurina, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Laurina contains desogestrel and ethinylestradiol, a combination known for a lower risk of androgenic side effects compared with older progestins. Its efficacy in preventing pregnancy is comparable to other combined pills, while its side‑effect profile may be more favourable for users sensitive to acne or weight changes.

Laurina tablets should be stored at ambient temperature, below 25 °C, in the original blister pack. Keep them away from excess moisture, heat and direct sunlight to maintain product stability throughout its shelf life.

Laurina is taken orally as a tablet. The usual practice is to swallow one tablet with water each day, preferably at the same time each day, to maintain consistent hormone levels and ensure effective contraception.

The most serious risks include venous or arterial thromboembolism, severe hypertension, and rare hepatic or gallbladder disorders. Women with a history of clotting disorders, smokers over 35, or those taking interacting medications should be closely monitored or avoid use.

Laurina should not be used by women who are pregnant, have known or suspected pregnancy, have a history of thromboembolic disease, uncontrolled hypertension, liver disease, or are smokers over the age of 35. It is also contraindicated in individuals with known hypersensitivity to desogestrel, ethinylestradiol or any tablet excipients.